Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
journal contribution
posted on 2023-05-21, 23:16 authored by Alhossain Khalafallah, Brain, TNo description available
History
Publication title
Mediterranean Journal of Hematology and Infectious DiseasesPagination
EJISSN
2035-3006Department/School
School of Health SciencesPublisher
Universita Cattolica del Sacro Cuore, Istituto di EmatologiaPlace of publication
ItalyRepository Status
- Restricted
Socio-economic Objectives
Diagnosis of human diseases and conditionsUsage metrics
Categories
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC